Visca D, Mori L, Tsipouri V, et al. AmbOx: A Randomised Controlled, Crossover Trial Evaluating the Effects of Ambulatory Oxygen on Health Status in Patients with Fibrotic Interstitial Lung Disease. ATS 2017, A7603.
Tweedelijns tarlatamab beter dan chemotherapie bij kleincellige longkanker
okt 2025 | Longoncologie